- Home
- Supplements
- Ashwagandha
- Perimenopause
Ashwagandha for Perimenopause
Ashwagandha has small positive trials in perimenopausal women for overall symptom burden, sleep, and stress — a reasonable complement to lifestyle measures, but no supplement approaches HRT for symptom relief.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 300 mg standardised extract (KSM-66 or similar) twice daily
- Expected timeframe
- 4-8 weeks
Protocol
- form
- KSM-66 or similar standardised root extract
- timing
- With meals; the evening dose can help with sleep disturbance
- duration
- 8 weeks
- titration
- Move to 300 mg twice daily - the dose used in the perimenopause trial
- measurement
- Menopause Rating Scale at baseline and week 8, plus a sleep quality score
- starting dose
- 300 mg standardised extract once daily with food
Evidence
What the studies say
No studies are yet linked to both Ashwagandha and Perimenopause.
Safety
Caveats
Generally well tolerated; rare liver-injury case reports exist. May increase thyroid hormone levels — caution with thyroid medication. Avoid in pregnancy.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.